To directly assess the anti-myeloma functionality of CD8+ T-cells, we tested the ability of BM-derived CD8+ T cells from healthy or myeloma-bearing mice to kill MOPC315.BM cells in vitro and to secrete IFNγ. Here, IFNG is linked to plasma cell myeloma.